| Literature DB >> 31313537 |
Irwin I Tendler1, Petr Bruza1, Michael Jermyn1,2, Antoine Fleury1,3, Benjamin B Williams4,5, Lesley A Jarvis4,5, Brian W Pogue1,2,5, David J Gladstone1,4,5.
Abstract
Previous work has shown that capturing optical emission from plastic discs attached directly to the skin can be a viable means to accurately measure surface dose during total skin electron therapy. This method can provide accurate dosimetric information rapidly and remotely without the need for postprocessing. The objective of this study was to: (1) improve the robustness and usability of the scintillators and (2) enhance sensitivity of the optical imaging system to improve scintillator emission detection as related to tissue surface dose. Baseline measurements of scintillator optical output were obtained by attaching the plastic discs to a flat tissue phantom and simultaneously irradiating and imaging them. Impact on underlying surface dose was evaluated by placing the discs on-top of the active element of an ionization chamber. A protective coating and adhesive backing were added to allow easier logistical use, and they were also subjected to disinfection procedures, while verifying that these changes did not affect the linearity of response with dose. The camera was modified such that the peak of detector quantum efficiency better overlapped with the emission spectra of the scintillating discs. Patient imaging was carried out and surface dose measurements were captured by the updated camera and compared to those produced by optically stimulated luminescence detectors (OSLD). The updated camera was able to measure surface dose with < 3 % difference compared to OSLD–Cherenkov emission from the patient was suppressed and scintillation detection was enhanced by 25 × and 7 × , respectively. Improved scintillators increase underlying surface dose on average by 5.2 ± 0.1 % and light output decreased by 2.6 ± 0.3 % . Disinfection had < 0.02 % change on scintillator light output. The enhanced sensitivity of the imaging system to scintillator optical emission spectrum can now enable a reduction in physical dimensions of the dosimeters without loss in ability to detect light output.Entities:
Keywords: biomedical optics; camera; medical imaging; optical devices; radiation oncology; scintillation
Year: 2019 PMID: 31313537 PMCID: PMC6630097 DOI: 10.1117/1.JBO.24.7.075001
Source DB: PubMed Journal: J Biomed Opt ISSN: 1083-3668 Impact factor: 3.170
Fig. 1Both “control” and “redesign” scintillator dosimeters mounted to a flat-faced phantom. “Control” scintillators are wrapped in cellophane and attached using medical tape. Zoomed-in view of the “redesigned” scintillator shows thicknesses of polyvinyl toluene (PVT) plastic, reflective paint, protective coating, and adhesive backing.
Fig. 2Impact of scintillator () thickness on surface dose. Reading obtained with bare IC, no dosimeters placed on-top shown as green dot, vertical green bar represents STD in IC measurements. 5% increase in surface dose from this baseline measurement shown as horizontal dotted green line. Pre- and postmodification refers to redesign process: application of clear coat and adhesive backing. “Redesigned” group of scintillators underwent the redesign process, while the “control” group did not. It should be noted that the “redesigned” scintillators in the pre- and postmodification sections are the same dosimeters. Cyan star shows impact of a nanoDot OSLD on surface dose. Horizontal dotted lines in each section represent mean of corresponding sample groups.
Fig. 3Scintillator light output tracked over various stages of the redesigning process. Varying shades of red and blue represent individual scintillators. Mean of each sample group is represented as a color-coded dotted line. “Coating” and “cleaning” represent light output measurement obtained following application of protective coating and cleaning with Sani-Cloth, respectively. Control group was not removed from the flat-faced phantom, and this group did not undergo coating or cleaning.
Fig. 4Emission spectra of the scintillator dosimeter (black solid line, right axis) overlaid with quantum detection efficiency spectra of the red- and blue-sensitive photocathodes (red and blue dashed lines, data correspond to left axis).
Fig. 5Sample images of a patient undergoing TSET in the posterior-anterior position. (a) Color photograph, (b) background image, (c) cumulative image captured by “red”-camera, and (d) cumulative image captured simultaneously during the same imaging session as shown in (c) by “blue” camera. Intensity values of Cherenkov and scintillation intensity maps shown in (c) and (d) are identically scaled. The SNR of the lower back scintillator (scintillation signal) and square ROI in the center of back (Cherenkov light) increased and decrease by and when comparing (c) to (d), respectively.
Fig. 6(a) Percent difference ( and ) between surface dose measured by scintillator and OSLD, per dosimetry site. (b) Relationship between surface dose measured by scintillator versus OSLD. Linear trendline and 95% confidence interval are displayed in black and green, respectively. Data points obtained by red- and blue-sensitive cameras are shown with different shades of red or blue color, respectively. and root-mean-square error for each patient data set are also shown.